Titus MA - Search Results

1

Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone.

Mohler JL, Titus MA, Wilson EM. Mohler JL, et al. Among authors: titus ma. Clin Cancer Res. 2011 Sep 15;17(18):5844-9. doi: 10.1158/1078-0432.CCR-11-0644. Epub 2011 Jun 24. Clin Cancer Res. 2011. PMID: 21705451 Free PMC article.

2

Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer.

Titus MA, Gregory CW, Ford OH 3rd, Schell MJ, Maygarden SJ, Mohler JL. Titus MA, et al. Clin Cancer Res. 2005 Jun 15;11(12):4365-71. doi: 10.1158/1078-0432.CCR-04-0738. Clin Cancer Res. 2005. PMID: 15958619

3

Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer.

Titus MA, Schell MJ, Lih FB, Tomer KB, Mohler JL. Titus MA, et al. Clin Cancer Res. 2005 Jul 1;11(13):4653-7. doi: 10.1158/1078-0432.CCR-05-0525. Clin Cancer Res. 2005. PMID: 16000557

4

Thioredoxin Reductase 1 Expression and Castration-recurrent Growth of Prostate Cancer.

Singh SS, Li Y, Ford OH, Wrzosek CS, Mehedint DC, Titus MA, Mohler JL. Singh SS, et al. Among authors: titus ma. Transl Oncol. 2008 Sep;1(3):153-7. doi: 10.1593/tlo.08145. Transl Oncol. 2008. PMID: 18795150 Free PMC article.

5

14-3-3{eta} Amplifies Androgen Receptor Actions in Prostate Cancer.

Titus MA, Tan JA, Gregory CW, Ford OH, Subramanian RR, Fu H, Wilson EM, Mohler JL, French FS. Titus MA, et al. Clin Cancer Res. 2009 Dec 15;15(24):7571-7581. doi: 10.1158/1078-0432.CCR-08-1976. Clin Cancer Res. 2009. PMID: 19996220 Free PMC article.

6

Atmospheric pressure photoionization tandem mass spectrometry of androgens in prostate cancer.

Lih FB, Titus MA, Mohler JL, Tomer KB. Lih FB, et al. Among authors: titus ma. Anal Chem. 2010 Jul 15;82(14):6000-7. doi: 10.1021/ac100460x. Anal Chem. 2010. PMID: 20560527 Free PMC article.

7

Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer.

Mohler JL, Titus MA, Bai S, Kennerley BJ, Lih FB, Tomer KB, Wilson EM. Mohler JL, et al. Among authors: titus ma. Cancer Res. 2011 Feb 15;71(4):1486-96. doi: 10.1158/0008-5472.CAN-10-1343. Epub 2011 Feb 8. Cancer Res. 2011. PMID: 21303972 Free PMC article.

8

5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.

Godoy A, Kawinski E, Li Y, Oka D, Alexiev B, Azzouni F, Titus MA, Mohler JL. Godoy A, et al. Among authors: titus ma. Prostate. 2011 Jul;71(10):1033-46. doi: 10.1002/pros.21318. Epub 2010 Dec 28. Prostate. 2011. PMID: 21557268 Free PMC article.

9

Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.

Titus MA, Zeithaml B, Kantor B, Li X, Haack K, Moore DT, Wilson EM, Mohler JL, Kafri T. Titus MA, et al. PLoS One. 2012;7(1):e30192. doi: 10.1371/journal.pone.0030192. Epub 2012 Jan 17. PLoS One. 2012. PMID: 22272301 Free PMC article.

10

Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.

Tan JA, Bai S, Grossman G, Titus MA, Harris Ford O, Pop EA, Smith GJ, Mohler JL, Wilson EM, French FS. Tan JA, et al. Among authors: titus ma. Mol Cell Endocrinol. 2014 Jan 25;382(1):302-313. doi: 10.1016/j.mce.2013.09.036. Epub 2013 Oct 5. Mol Cell Endocrinol. 2014. PMID: 24103312 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters